- 24 Tech Roqad st Ny 10023
- editech@mail.com
Our Board of Directors comprises industry veterans and strategic leaders who guide Cohance’s vision and growth. Their expertise spans pharmaceuticals, private equity, and corporate governance, ensuring we remain a trusted partner in health science innovation.
Mr. K G Ananthakrishnan joined as an Independent Director of the Company effective 29th September 2023. He has had a distinguished career spanning over four decades in the pharmaceutical industry.
He served as Director General of the Organization of Pharmaceutical Producers of India (OPPI) and Co-Chair of the Pharma Committee at CII, where he played a key role in shaping public policy. He holds a Masters in Marketing Management from JBIMS, Mumbai, and a Bachelors in Science from Osmania University, Hyderabad. He has also completed executive programs at Wharton Business School and INSEAD.
Beginning his career with Novartis India in 1976, he held senior roles at Pharmacia, Pfizer, and Fulford (India). As VP and MD – South Asia Region for MSD, he led a transformation into a high-growth company.
Other Directorships / Full-time Positions in Body Corporate Entities:
SI | Name of the Company / Body Corporate | Position |
1 | Gujarat Themis Biosyn Ltd | Independent Director |
2 | Rubicon Research Limited | Independent Director |
3 | Sapala Organics Private Limited | Independent Director |
4 | Punjab National Bank | Non-Executive Chairman |
5 | Mango Cancer Care Foundation | Non-Executive Director |